
Major Scope
- Lung Cancer
- Colorectal Cancer
- Pancreatic Cancer
- Breast Cancer
- Prostate Cancer
- Liver Cancer
- Leukemia
- Bladder Cancer
- Kidney Cancer
- Endometrial Cancer
- Oncology Case Reports
- Radiation Therapy
Abstract
Citation: Clin Oncol. 2019;4(1):1626.DOI: 10.25107/2474-1663-v4-id1626
Acute Aortic Thrombosis Related to Adjuvant Capecitabine-Oxaliplatin in a Chinese Patient with Resected Adenocarcinoma of Sigmoid Colon
Henry CY Wong, Fiona MY Lim and Ashley CK Cheng
Department of Oncology, Princess Margaret Hospital, Hong Kong
*Correspondance to: Henry CY Wong
PDF Full Text Case Report | Open Access
Abstract:
Aortic thrombosis is a rare disease entity which has been reported to be related to malignancy and chemotherapeutic agents. Here we present the first case in literature about a colon cancer patient with well-controlled vascular risk factors who developed acute aortic thrombosis after the first cycle of adjuvant chemotherapy with capecitabine-oxaliplatin. Risk factors and causal relationship between systemic anti-cancer agents and this condition are reviewed and discussed.
Keywords:
Aortic thrombosis; Arterial thromboembolism; Capecitabine; Oxaliplatin
Cite the Article:
Wong HCY, Lim FMY, Cheng ACK. Acute Aortic Thrombosis Related to Adjuvant Capecitabine-Oxaliplatin in a Chinese Patient with Resected Adenocarcinoma of Sigmoid Colon. Clin Oncol. 2019; 4: 1626.
Journal Basic Info
- Impact Factor: 3.231**
- H-Index: 11
- ISSN: 2474-1663
- DOI: 10.25107/2474-1663
- PubMed NLM ID: 101705590